According to research report the sinus dilation devices market is expected to reach USD 2.78 billion by 2023 from USD 1.80 billion in 2018, at a CAGR of 9.1%. The growth of the market can be attributed to the high prevalence of chronic sinusitis, growing preference for minimally invasive procedures, benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, and favorable reimbursement scenario for sinus procedures in developed countries
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810
Benefits of balloon sinuplasty / sinus dilation over conventional sinus surgeries to drive the growth of sinus dilation devices market
ENT Clinics/In Office
Increasing number of treatable patients in ENT clinics, faster recovery time, cost-effectiveness, and growing preference for minimally invasive techniques are some of the factors driving the growth of this segment. In 2016, out of the 188,000 patients suffering from chronic sinusitis, 160,000 (85%) patients performed the balloon sinus dilation procedure in ENT clinics/in office in the US (Source: Entellus Presentation 2017.
Ambulatory Surgical Centres (ASCs)
Ambulatory surgical centres (ASCs) provide healthcare services and primary care to patients in an outpatient capacity. The minimally invasive procedure such as balloon sinus dilation can be easily performed in ASCs. Factors such as better infrastructure in ASCs are driving the growth of this segment. The cost-effectiveness coupled with the better reimbursement scenario than hospitals is also driving the growth of this segment.
Hospitals is one of the patient care settings where sinus dilation devices are extensively used.
This segment holds the largest market share due to high number of outpatient sinus dilation procedures, the advantages of having integrated healthcare facilities, the availability of technologically advanced infrastructures, and the ability to perform complex sinus surgeries.
North America is expected to dominate the sinus dilation devices market in 2018
In 2018, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to rapidly increasing geriatric population, rising prevalence of chronic sinusitis, higher adoption of new technologies among ENT surgeons and otolaryngologists, favorable reimbursement scenario, and the presence of major players in this region.
Get Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=64349810
Key players in the Sinus Dilation Devices Market include The major players in the market are Entellus Medical Inc. (a subsidiary of Stryker) (US), Acclarent Inc. (a subsidiary of Johnson & Johnson) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT Inc. (US), and Olympus Corporation (Japan). Other players in the market include Meril Life Sciences Pvt. Ltd. (India), SinuSys Corporation (US), InAccel (India), Jilin Coronado Medical Ltd. (China) and dalENT Medical (US). These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new technologies and products in the sinus dilation devices market.